Qatar
Prof. Martin studied Medicine and Human Biology in Germany where he received his MD and PhD from University Marburg. He received his dermatology training at University in Muenster and Univ. California San Francisco. Professor Martin Steinhoff is now Chairman at the Dept. of Dermatology and Director of the Translational Research Institute as well as Residency Program Director at Hamad Medical Corporation, Qatar. He is Full-Professor at Weill-Cornell Universities in New York and Qatar, Hamad bin Khalifa University and Qatar University. Prof. Steinhoff’s main interest is neuroimmunology where his group described various new mechanisms like the first histamine-independent itch pathway, published in Nature Medicine, and described the first cytokine receptor on human sensory nerves which has led to development of new medications. Prof. Martin published around 300 peer-reviewed articles (H-index: 88), over 40 book chapters, and holds numerous patents. His research has been funded with >60 Mio Euro so far. His group received 2023 the PPM award to study precision medicine based pathways and new treatments for atopic dermatitis. Finally, Prof. Martin was also PI on various clinical trials and received several prestigious international research-awards, and is honorary member of several Societies for Dermatology.